Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Diabetes is associated with increased risk of hepatocellular carcinoma in non-alcoholic steatohepatitis with cirrhosis-implications for surveillance and future pharmacotherapy.

Literature DB >> 32355688

Diabetes is associated with increased risk of hepatocellular carcinoma in non-alcoholic steatohepatitis with cirrhosis-implications for surveillance and future pharmacotherapy.

Michael P Johnston¹, Janisha Patel¹, Christopher D Byrne^2,3.

Abstract

Entities: Disease

Year: 2020 PMID： 32355688 PMCID： PMC7188527 DOI： 10.21037/hbsn.2019.10.09

Source DB: PubMed Journal: Hepatobiliary Surg Nutr ISSN： 2304-3881 Impact factor: 7.293

× No keyword cloud information.

22 in total

1. An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice.

Authors: Na-Ri Shin; June-Chul Lee; Hae-Youn Lee; Min-Soo Kim; Tae Woong Whon; Myung-Shik Lee; Jin-Woo Bae
Journal: Gut Date: 2013-06-26 Impact factor: 23.059

2. Systematic review with meta-analysis: risk of hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis compared to other liver diseases.

Authors: Jonathan G Stine; Brian J Wentworth; Alex Zimmet; Mary E Rinella; Rohit Loomba; Stephen H Caldwell; Curtis K Argo
Journal: Aliment Pharmacol Ther Date: 2018-08-22 Impact factor: 8.171

3. Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases.

Authors: Jorge A Marrero; Laura M Kulik; Claude B Sirlin; Andrew X Zhu; Richard S Finn; Michael M Abecassis; Lewis R Roberts; Julie K Heimbach
Journal: Hepatology Date: 2018-08 Impact factor: 17.425

4. Diabetes Is Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Cirrhosis From Nonalcoholic Fatty Liver Disease.

Authors: Ju Dong Yang; Fowsiyo Ahmed; Kristin C Mara; Benyam D Addissie; Alina M Allen; Gregory J Gores; Lewis R Roberts
Journal: Hepatology Date: 2019-10-21 Impact factor: 17.425

Review 5. Anti-diabetic medications and the risk of hepatocellular cancer: a systematic review and meta-analysis.

Authors: Siddharth Singh; Preet Paul Singh; Abha Goyal Singh; Mohammad Hassan Murad; William Sanchez
Journal: Am J Gastroenterol Date: 2013-02-05 Impact factor: 10.864

6. Underreporting of liver transplant waitlist removals due to death or clinical deterioration: results at four major centers.

Authors: David Goldberg; Benjamin French; James Trotter; Kirti Shetty; Thomas Schiano; K Rajender Reddy; Scott D Halpern
Journal: Transplantation Date: 2013-07-27 Impact factor: 4.939

7. Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: a pathological analysis.

Authors: Valérie Paradis; Stéphane Zalinski; Emna Chelbi; Nathalie Guedj; Françoise Degos; Valérie Vilgrain; Pierre Bedossa; Jacques Belghiti
Journal: Hepatology Date: 2009-03 Impact factor: 17.425

Diabetes is associated with increased risk of hepatocellular carcinoma in non-alcoholic steatohepatitis with cirrhosis-implications for surveillance and future pharmacotherapy.

1. An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice.

2. Systematic review with meta-analysis: risk of hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis compared to other liver diseases.

3. Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases.

4. Diabetes Is Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Cirrhosis From Nonalcoholic Fatty Liver Disease.

Review 5. Anti-diabetic medications and the risk of hepatocellular cancer: a systematic review and meta-analysis.

6. Underreporting of liver transplant waitlist removals due to death or clinical deterioration: results at four major centers.

7. Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: a pathological analysis.

Review 8. The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence.

Review 9. Multi-drug approaches to NASH: what's in the development pipeline?

10. Gut microbiota-derived propionate reduces cancer cell proliferation in the liver.

1. Transient elastography in patients at risk of liver fibrosis in primary care: a follow-up study over 54 months.